General MedicationsOPHTHALMICGeneric
CHIBROXIN
NORFLOXACIN
Standard Dose
0.3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CHIBROXIN is listed in Drugs@FDA under application 019757 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient NORFLOXACIN Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.3% Sponsor MERCK Submission history Latest submission status date: 2001-02-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview CHIBROXIN is listed in Drugs@FDA under application 019757 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NORFLOXACIN Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.3% Sponsor MERCK Submission history Latest submission status date: 2001-02-05 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.